4DMedical Limited (ASX: 4DX)
Health Care · Health Care Technology · AU
AU$4.05
+2.53% today · +73.8% 1Y
4DMedical Limited (ASX: 4DX) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $1.70B and employs 181 people.
Over the last twelve months the share price has gained 73.8%, trading between 1.40 and 7.55.
Tweenvest scores 4DMedical Limited across four factors: quality 36/100, value 58/100, growth 100/100. Its strongest factor is growth.
4DX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.70B
- Revenue (TTM)
- $4.89M
- P/E
- —
- EPS
- -0.38
- Dividend yield
- —
- Beta (5Y)
- 1.84
- 52-week high
- AU$7.55
- 52-week low
- AU$1.40
- Avg volume (3M)
- —
- Shares outstanding
- 601.57M
- Employees
- 181
- Next earnings
- —
About 4DMedical Limited
Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Technology, an advanced system for four-dimensional lung imaging. Beyond this core offering, its suite of products includes a software-as-a-service (SaaS) delivery model, specialized XV lung ventilation analysis software, and Permetium—a preclinical imaging system designed to quantify regional changes in pulmonary function. Additionally, the firm provides the AccuVent 200, a ventilator tailored for small animals.
- ISIN
- AU0000095416
- Founded
- 2012
- Listed since
- Aug 7, 2020
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HeartFlow, Inc.NasdaqGS: HTFL | $4.33B | $49.74 | +4.43% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.04B | Rs1,716.60 | -3.37% |
| Winning Health Technology Group Co., Ltd.SZSE: 300253 | $2.38B | CN¥7.24 | +3.72% |
| Schrödinger, Inc.NasdaqGS: SDGR | $2.04B | $27.28 | +3.37% |
| CompuGroup Medical SE & Co. KGaAHMSE: COP | $1.69B | €29.20 | -0.17% |
| JMDC Inc.TSE: 4483 | $1.54B | ¥3,720.00 | +2.62% |
| Certara, Inc.NasdaqGS: CERT | $1.39B | $9.13 | +5.67% |
| GoodRx Holdings, Inc.NasdaqGS: GDRX | $1.17B | $3.43 | +2.08% |
Figures last refreshed Oct 11, 2026.